Role of pharmacologic tests in the treatment of primary pulmonary hypertension
Authors:
- Nazzareno GalièNGNazzareno Galiè
- Gianpaolo UssiaGUGianpaolo Ussia
- Paola PassarelliPPPaola Passarelli
- Riccardo ParlangeliRPRiccardo Parlangeli
- Angelo BranziABAngelo Branzi
- Bruno MagnaniBMBruno Magnani
- 1 January 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (3) , 55A-62A
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Short-term effectiveness of nifedipine in secondary pulmonary hypertensionThe American Journal of Cardiology, 1993
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993
- Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failureInternational Journal of Cardiology, 1988
- The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.Circulation, 1985
- On pulmonary vascular resistance: The need for more precise definitionThe American Journal of Cardiology, 1985
- Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertensionThe American Journal of Cardiology, 1985
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Primary Pulmonary HypertensionCirculation, 1970
- Effect of Acetylcholine on Pulmonary Vascular Resistance in a Patient with Idiopathic Pulmonary HypertensionCirculation, 1959